Clinical Trial Update: Daratumumab to Treat Active Lupus Nephritis [Phase 2]

View source ↗

Summary

A Phase 2 trial is investigating daratumumab for active lupus nephritis, and the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Lupus Nephritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING